» Articles » PMID: 27709558

DNA Copy Number Alterations, Gene Expression Changes and Disease-free Survival in Patients with Colorectal Cancer: a 10 Year Follow-up

Overview
Publisher Springer
Date 2016 Oct 7
PMID 27709558
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: DNA copy number alterations (CNAs) and gene expression changes have amply been encountered in colorectal cancers (CRCs), but the extent at which CNAs affect gene expression, as well as their relevance for tumor development, are still poorly defined. Here we aimed at assessing the clinical relevance of these parameters in a 10 year follow-up study.

Methods: Tumors and normal adjacent colon mucosa, obtained at primary surgery from 21 CRC patients, were subjected to (i) high-resolution array CGH (a-CGH) for the detection of CNAs and (ii) microarray-based transcriptome profiling for the detection of gene expression (GE) changes. Correlations between these genomic and transcriptomic changes and their associations with clinical and histopathological parameters were assessed with the aim to identify molecular signatures associated with disease-free survival of the CRC patients during a 10 year follow-up.

Results: DNA copy number gains were frequently detected in chromosomes 7, 8q, 13, 19, 20q and X, whereas DNA copy number losses were frequently detected in chromosomes 1p, 4, 8p, 15, 17p, 18, 19 and 22q. None of these alterations were observed in all samples. In addition, we found that 2,498 genes were up- and that 1,094 genes were down-regulated in the tumor samples compared to their corresponding normal mucosa (p < 0.01). The expression of 65 genes was found to be significantly associated with prognosis (p < 0.01). Specifically, we found that up-regulation of the IL17RA, IGF2BP2 and ABCC2 genes, and of genes acting in the mTOR and cytokine receptor pathways, were strongly associated with a poor survival. Subsequent integrated analyses revealed that increased expression levels of the MMP9, BMP7, UBE2C, I-CAM, NOTCH3, NOTCH1, PTGES2, HMGB1 and ERBB3 genes were associated with copy number gains, whereas decreased expression levels of the MUC1, E2F2, HRAS and SIRT3 genes were associated with copy number losses. Pathways related to cell cycle progression, eicosanoid metabolism, and TGF-β and apoptosis signaling, were found to be most significantly affected.

Conclusions: Our results suggest that CNAs in CRC tumor tissues are associated with concomitant changes in the expression of cancer-related genes. In other genes epigenetic mechanism may be at work. Up-regulation of the IL17RA, IGF2BP2 and ABCC2 genes, and of genes acting in the mTOR and cytokine receptor pathways, appear to be associated with a poor survival. These alterations may, in addition to Dukes' staging, be employed as new prognostic biomarkers for the prediction of clinical outcome in CRC patients.

Citing Articles

Copy number amplification-induced overexpression of lncRNA LOC101927668 facilitates colorectal cancer progression by recruiting hnRNPD to disrupt RBM47/p53/p21 signaling.

Wang Z, Han H, Zhang C, Wu C, Di J, Xing P J Exp Clin Cancer Res. 2024; 43(1):274.

PMID: 39350250 PMC: 11440719. DOI: 10.1186/s13046-024-03193-7.


Upregulation of sperm-associated antigen 5 expression in endometrial carcinoma was associated with poor prognosis and immune dysregulation, and promoted cell migration and invasion.

Chen M, Wang D, Xu Y, Yang C Sci Rep. 2024; 14(1):13415.

PMID: 38862557 PMC: 11166665. DOI: 10.1038/s41598-024-64354-4.


Copy number variations of are prognostic biomarkers for hepatocellular carcinoma.

Yu X, Huang J, Wu S, Huang Y, Shan Y, Lu C Transl Cancer Res. 2022; 9(2):698-706.

PMID: 35117415 PMC: 8797802. DOI: 10.21037/tcr.2019.11.52.


The role of BCL9 genetic variation as a biomarker for hepatitis C-related hepatocellular carcinoma in Egyptian patients.

Abbas E, Barakat A, Hassany M, Youssef S J Genet Eng Biotechnol. 2022; 20(1):4.

PMID: 34978646 PMC: 8724383. DOI: 10.1186/s43141-021-00282-4.


Characterization of the Clinical Significance of PD-1/PD-Ls Expression and Methylation in Patients With Low-Grade Glioma.

Mei J, Cai Y, Xu R, Yang X, Zhou W, Wang H Technol Cancer Res Treat. 2021; 20:15330338211011970.

PMID: 33955303 PMC: 8111557. DOI: 10.1177/15330338211011970.


References
1.
Ried T, Knutzen R, Steinbeck R, Blegen H, Schrock E, Heselmeyer K . Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer. 1996; 15(4):234-45. DOI: 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2. View

2.
Ledel F, Hallstrom M, Ragnhammar P, Ohrling K, Edler D . HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome. Eur J Cancer. 2013; 50(3):656-62. DOI: 10.1016/j.ejca.2013.11.008. View

3.
Nakao M, Kawauchi S, Furuya T, Uchiyama T, Adachi J, Okada T . Identification of DNA copy number aberrations associated with metastases of colorectal cancer using array CGH profiles. Cancer Genet Cytogenet. 2008; 188(2):70-6. DOI: 10.1016/j.cancergencyto.2008.09.013. View

4.
Nastase A, Paslaru L, Herlea V, Ionescu M, Tomescu D, Bacalbasa N . Expression of interleukine-8 as an independent prognostic factor for sporadic colon cancer dissemination. J Med Life. 2014; 7(2):215-9. PMC: 4197484. View

5.
Davidson B, Rosenfeld Y, Holth A, Hellesylt E, Trope C, Reich R . VICKZ2 protein expression in ovarian serous carcinoma effusions is associated with poor survival. Hum Pathol. 2014; 45(7):1520-8. DOI: 10.1016/j.humpath.2014.03.005. View